JXXD Citrate-Based Hemodialysis Powder is designed for hemodialysis in patients with acute/chronic renal failure and drug poisoning, holding relevant production licenses and registrations. Crafted with imported high-quality dialysis-grade raw materials and produced in a 10,000-class purification area, it ensures safety via advanced automatic vacuum feeding and packaging lines.

Its excellent quality is validated by atomic absorption spectrophotometry for accurate ion content. Key benefits include low inflammatory response, reduced blood pressure fluctuations, and minimized heparin use, making it liver-friendly even for patients with liver failure. It enhances dialyzer efficiency by reducing clotting, increases Kt/V value, removes more toxins (like BETA-2), and improves overall dialysis outcomes, ensuring reliable and effective treatment support.